Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4
“This expands the spectrum of the TEER-suitable patients and the formerly untreatable patients,” a researcher says.
Stay updated with breaking news from Ralph Stephan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“This expands the spectrum of the TEER-suitable patients and the formerly untreatable patients,” a researcher says.
BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter... | September 17, 2022
Post-approval study suggests growing pool of TEER-suitable patients
BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation EW announced results from CLASP IID, the first randomized controlled trial tha
/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced results from CLASP IID, the first randomized controlled trial that directly compares two...